Lydia Dingle (Karen Blick) will provide a listening ear for the family of Emmerdale's April Windsor (Amelia Flanagan) next week, as the traumatised teen settles back in at home. Viewers learned ...

Leerink Partnrs also issued estimates for Aclaris Therapeutics’ FY2026 earnings at ($0.74) EPS, FY2027 earnings at ($0.89) EPS and FY2028 earnings at ($1.19) EPS. Get Aclaris Therapeutics alerts: ...

An investment banker who left Goldman Sachs & Co. for Leerink Partners LLC advanced part of her lawsuit saying she was denied promised bonuses and deferred grant awards worth millions of dollars. The ...

Leerink Partnrs also issued estimates for Twist Bioscience’s Q4 2025 earnings at ($0.50) EPS, FY2025 earnings at ($2.18) EPS, Q1 2026 earnings at ($0.49) EPS, Q2 2026 earnings at ($0.48) EPS, Q3 ...

Fintel reports that on February 6, 2025, Leerink Partners downgraded their outlook for Hologic (NasdaqGS:HOLX) from Outperform to Market Perform. Analyst Price Forecast Suggests 20.21% Upside As ...

Leerink downgraded Hologic (HOLX) to Market Perform from Outperform with a price target of $75, down from $80, following the fiscal Q1 report. The company continues to experience a number of ...

Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals (WBAG:REGN) from Market Perform to Outperform. There are 2,472 funds or institutions ...

Leerink upgraded Regeneron (REGN) to Outperform from Market Perform with a price target of $834, up from $762. The shares have fallen 35% over the past six months, creating an opportunity to ...